Patient Guide: Efficacy of Tedopi Plus Docetaxel or Tedopi Plus Nivolumab as Second-line Therapy in Metastatic Non-small-cell Lung Cancer Progressing After First-line Chemo-immunotherapy (Combi-TED)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 23 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04884282
Status: ACTIVE_NOT_RECRUITING
Condition: Metastatic Non Small Cell Lung Cancer
Phase: PHASE2

Find a Study Location Near You

This study is available at 23 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Avignon,
  • Cholet,
  • Mulhouse,
  • • And 20 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily